Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β

Clinical Cancer Research

Volumn 17, Issue 13, 2011, Pages 4296-4308

  Lohr, Jennifer ^a   Ratliff, Thomas ^a   Huppertz, Andrea ^a   Ge, Yingzi ^b   Dictus, Christine ^a   Ahmadi, Rezvan ^a   Grau, Stefan ^c   Hiraoka, Nobuyoshi ^d   Eckstein, Volker ^a   Ecker, Rupert C ^e   Korff, Thomas ^a   Von Deimling, Andreas ^a   Unterberg, Andreas ^a   Beckhove, Philipp ^b   Herold Mende, Christel ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e TissueGnostics GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD3 ANTIGEN; CD8 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; HEMOPOIETIC GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; PLATELET DERIVED GROWTH FACTOR AB; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; EFFECTOR CELL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLIOBLASTOMA; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ANGIOGENESIS INDUCING AGENTS; CELL ADHESION MOLECULES; CELL MOVEMENT; DISEASE PROGRESSION; DOWN-REGULATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOCYTES, TUMOR-INFILTRATING; PROTEIN KINASE INHIBITORS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 79960301311     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-2557     Document Type: Article

References (49)

1. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004;64:6892-9. (Pubitemid 39330996)
2. Lamszus K, Kunkel P, Westphal M. Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir Suppl 2003;88:169-77.
3. Cabarrocas J, Bauer J, Piaggio E, Liblau R, Lassmann H. Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes. Eur J Immunol 2003;33:1174-82. (Pubitemid 36609135)
4. Grauer OM, Wesseling P, Adema GJ. Immunotherapy of diffuse glioma: biological background, current status and future developments. Brain Pathol 2009;19:674-93.
5. Walker PK, Calzascia T, Dietrich PY. All in the head: obstacles for immune rejection of brain tumors. Immunology 2002;107:28-38.
6. Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 2005;26:485-95. (Pubitemid 41139258)
7. Davies DC. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 2002;200:639-46. (Pubitemid 34823055)
8. Rascher G, Fischmann A, Kröger S, Duffner F, Grote EH, Wolburg H. Extracellular matrix and the blood-brain-barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathol 2002;104:85-91 (Pubitemid 36075363)
9. Prins RM, Liau LM. Cellular immunity and immunotherapy of brain tumors. Front Biosc 2004;9:3124-36.
10. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006;24:99-146.
11. Fantini MC, Becker C, Montelione G, Pallone F, Galle PR, Neurath NL. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004;172:5149-53. (Pubitemid 38542009)
12. Fecci PE, Mitchell DA, Whitesides JF, Xie W, Friedman AH, Archer GE, et al. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains immune defects in patients with malignant glioma. Cancer Res 2006;66:3294-302.
13. Tate MC, Aghi MK. Biology of angiogenesis and invasion in glioma. Neurotherapeutics 2009;6:447-57.
14. Dirkx AE, Oude Egbrink MG, Kuijpers MJ, van der Niet ST, Heijnen VV, Bouma-ter Steege JC, et al. Tumor angiogenesis modulates leukocyte- vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res 2003;63:2322-39.
15. Tromp SC, oude Egbrink MG, Dings RP, van Velzen S, Slaaf DW, Hillen HF, et al. Tumor angiogenesis factors reduce leukocyte adhesion in vivo. Int Immunol 2000;12:671-6.
16. Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic growth factors. Cancer Res 1996;56:1111-7. (Pubitemid 26065408)
17. Griffioen AW, Damen CA, Blijham GH, Groenewegen G. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 1996;88:667-73. (Pubitemid 26240398)
18. Bouma-ter Steege J, Baeten C, Thijssen V, Satijn SA, Verhoeven IC, Hillen HF, et al. Angiogenic profile of breast carcinoma determines leukocyte infiltration. Clin Cancer Res 2004;10:7171-8. (Pubitemid 39487702)
19. Kitayama J, Nagawa H, Yasuhara H, Tsuno N, Kimura W, Shibata Y, et al. Suppressive effect of basic fibroblast growth factor on transendothelial emigration of CD4+ T-lymphocyte. Cancer Res 1994;54:4729-33. (Pubitemid 24276503)
20. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14.
21. Lyck R, Reiss Y, Gerwin N, Greenwood J, Adamson P, Engelhardt B. T-cell interaction with ICAM-1/ICAM-2 double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells. Blood 2003;102:3675-83. (Pubitemid 37409388)
22. Mazzolini G, Narvaiza I, Bustos M, Duarte M, Tirapu I, Bilbao R, et al. αvβ3 Integrin-mediated adenoviral transfer of interleukin-12 at the periphery of hepatic colon cancer metastases induces VCAM-1 expression and T-cell recruitment. Mol Ther 2001;3:665-72. (Pubitemid 32509863)
23. Ueda R, Low KL, Zhu X, Fujita M, Sasaki K, Whiteside TL, et al. Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma. J Transl Med 2007;5:68.
24. Palma L, Di Lorenzo N, Guidetti B. Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 1978;49:854-61. (Pubitemid 9062914)
25. Brooks WH, Markesbery WR, Gupta GD, Roszman TL. Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 1978;4:219-24. (Pubitemid 8389815)
26. Safdari H, Hochberg FH, Richardson EP Jr. Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas. Surg Neurol 1985;23:221-6. (Pubitemid 15138393)
27. Schiffer D, Cavicchioli D, Giordana MT, Palmucci L, Piazza A. Analysis of some factors effecting survival in malignant gliomas. Tumori1979;65:119-25.
28. Mittelbronn M, Simon P, Löffler C, Capper D, Bunz B. Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells. J Neuroimmunol 2007;189:50-8. (Pubitemid 47379433)
29. Heimberger AB, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Sun W. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas. Clin Cancer Res 2008;14:5166-72.
30. Jacobs JF, Idema AJ, Bol KF, Grotenhuis JA, de Vries IJ, Wesseling P, et al. Prognostic significance and mechanism of Treg infiltration in human brain tumors. J Neuroimmunol 2010;225:195-9.
31. Karcher S, Steiner HH, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, et al. Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 2006;118:2182-9.
32. Wang RF. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer. Hum Immunol 2008;69:811-14.
33. Ebert AM, Tan BS, Browning J, Svobodova S, Russell SE, Kirkpatrick N, et al. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 2008;68:3001-9. (Pubitemid 351556301)
34. Siegmund S, Rückert B, Ouaked N, Bürgler S, Speiser A, Akdis CA, et al. Unique phenotype of human tonsillar and in vitro-induced Foxp3+CD8+ T cells. J Immunol 2009;182:2124-30.
35. Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, et al. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res 2004;64:7954-61. (Pubitemid 39446929)
36. Stevens A, Klöter I, Roggendorf W. Inflammatory infiltrates and natural killer cell presence in human brain tumors. Cancer 1988;61:738-43. (Pubitemid 18037925)
37. Rossi ML, Jones NR, Candy E, Nicoll JA, Compton JS, Hughes JT, et al. The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropath 1989;78:189-93. (Pubitemid 19160923)
38. El Andaloussi A, Lesniak MS. CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas. J Neurooncol 2007;83:145-52. (Pubitemid 46784987)
39. Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautès-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010;29:1093-102.
40. Senger DR, Van De Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Met Res 1993;12:303-24. (Pubitemid 23293287)
41. Di Lorenzo N, Palma L, Nicole S. Lymphocytic infiltration in long-survival glioblastomas: possible host's resistance. Acta Neurochir (Wien)1977;39:27-33. (Pubitemid 8188642)
42. Böker DK, Kalff R, Gullotta F, Weekes-Seifert S, Möhrer U. Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma. Clin Neuropathol 1984;3:143-7.
43. Yang I, Tihan T, Han SJ, Wrensch MR, Wiencke J, Sughrue ME, et al. CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci 2010;17:1381-85.
44. Ahmadzadeh M, Johnson LA, Heemskerk B, Wunderlich JR, Dudley ME, White DE, et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 2009;114:1537-44.
45. Kasper HU, Drebber U, Stippel DL, Dienes HP, Gillessen A. Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma. World J Gastroenterol 2009;15:5053-7.
46. Grauer OM, Nierkens S, Bennink E, Toonen LW, Boon L, Wesseling P, et al. CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. Int J Cancer 2007;121:95-105. (Pubitemid 46753856)
47. El Andaloussi A, Lesniak MS. An increase in CD4+CD25+FOXP3+regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme. J Neurooncol 2006;8:234-43. (Pubitemid 46542648)
48. Platten M, Wick W, Weller M. Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech 2001;52:401-10. (Pubitemid 32167828)
49. Tran TT, Uhl M, Ma JY, Janssen L, Sriram V, Aulwurm S, et al. Inhibiting TGF-β signaling restores immune surveillance in the SMA-560 glioma model. Neuro-Oncol 2007;9:259-70. (Pubitemid 47169658)